Success Metrics

Active Trials
1(20%)

Phase Distribution

Ph not_applicable
3
60%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting2
unknown1
Withdrawn1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

not_yet_recruiting240%
unknown120%
withdrawn120%
active_not_recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
withdrawn

Cost-effectiveness Analyses for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery in the UK

NCT07108634
active_not_recruitingnot_applicable

Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI

NCT06811805
not_yet_recruitingnot_applicable

Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury

NCT07123935
not_yet_recruitingnot_applicable

PuO2 in RenalGuard Pilot Study

NCT06886191
unknownphase_3

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients

NCT01456013

Clinical Trials (5)

Showing 5 of 5 trials
NCT07108634

Cost-effectiveness Analyses for the Prevention of Acute Kidney Injury in Patients Undergoing Cardiac Surgery in the UK

Withdrawn
NCT06811805Not Applicable

Post-Marketing Study to Assess the Safety & Efficacy of RenalGuard® Therapy for Prevention CSA-AKI

Active Not Recruiting
NCT07123935Not Applicable

Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury

Not Yet Recruiting
NCT06886191Not Applicable

PuO2 in RenalGuard Pilot Study

Not Yet Recruiting
NCT01456013Phase 3

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5